Smith Jason Drew

CIK 00018214791 companyPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001821479

Recent Transactions

50 trades

Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-09-08$19.11/sh−1,520→ 43,305 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-09-07−3,333→ 3,334 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-09-07+3,333→ 44,825 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-07-28$19.14/sh−7,522→ 41,492 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-07-28+16,500→ 49,014 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31−2,500→ 0 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31$11.14/sh−2,767→ 32,514 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31$11.14/sh−3,354→ 29,781 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31+10,000→ 10,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31+5,500→ 35,281 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31+2,500→ 27,726 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31$11.14/sh−1,258→ 26,468 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31−6,667→ 6,667 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31+6,667→ 33,135 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31−5,500→ 11,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-09-09−3,333→ 6,667 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-09-09+3,333→ 26,747 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-09-09$13.08/sh−1,521→ 25,226 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-02-01$15.78/sh−3,328→ 23,414 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-02-01$15.78/sh−1,248→ 20,076 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-02-01$15.78/sh−417→ 18,824 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31$15.74/sh−1,248→ 20,076 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31+6,666→ 26,742 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31+16,500→ 16,500 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31−834→ 0 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31$15.74/sh−417→ 18,824 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31+2,500→ 21,324 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31$15.74/sh−3,328→ 23,414 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31−2,500→ 2,500 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31−6,666→ 13,334 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31+834→ 19,241 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-09-07+10,000→ 10,000 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-08-31$18.01/sh−3,800→ 18,407 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-08-31−8,334→ 0 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-08-31+8,334→ 22,207 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31$10.12/sh−1,227→ 13,873 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31$10.12/sh−409→ 12,600 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31−2,500→ 5,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31+2,500→ 15,100 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31+833→ 13,009 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31−833→ 834 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31+20,000→ 20,000 total
Award
UroGen Pharma Ltd.$URGN
Employee Stock Option (right to buy)
2023-01-31+40,000→ 40,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2022-08-31−8,333→ 8,334 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-08-31$7.21/sh−3,606→ 12,176 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-08-31+8,333→ 15,782 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-31+833→ 7,863 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-31$7.58/sh−414→ 7,449 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2022-01-31+30,000→ 30,000 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2022-01-31+7,500→ 7,500 total

Companies

UroGen Pharma Ltd.
General Counsel
$URGN

Recent Filings

Address

400 ALEXANDER PARK DRIVE

PRINCETON, NJ, 08540

View on SEC.gov